Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes

Diabetes Care

Volumn 31, Issue 6, 2008, Pages 1112-1117

  Ashwell, Simon G ^a,e   Bradley, Clare ^b   Stephens, James W ^c   Witthaus, Elke ^d   Home, Philip D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c SANOFI   (France)

^d Health Outcomes Research   (Germany)

^e JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EVENING DOSAGE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; BLOOD; BODY MASS; DRUG COMBINATION; LIFESTYLE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; LIFE STYLE; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 48649097585     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1183     Document Type: Article

References (23)

1. Speight J, Bradley C: DAFNE: improved quality of life as a result of intensified treatment is counter-intuitive to many clinicians [article online], 2002. Available from http://bmj.com/cgi/eletters/325/7367/746#26769. Accessed 15 April 2008
2. Bradley C, Pierce MB, Hendrieckx C, Riazi A, Barendse S: Diabetes mellitus. In Health Psychology. Johnston M, Johnston DW, Eds. [Vol. 8 in Comprehensive Clinical Psychology. Bellack AS, Hersen M, Eds.] Oxford, U.K., Elsevier Science, 1998, p. 277-304
3. Howorka K: Preface. In Functional Insulin Treatment, 2nd ed. Berlin, Springer Verlag; Authors preface. 1996
4. Witthaus E, Stewart J, Bradley C: Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with type 1 diabetes. Diabet Med 18:619-626, 2001
5. Ahmed A, Home P: Optimal provision of daytime NPH insulin in patients using the insulin analog lispro. Diabetes Care 21: 1707-1713, 1998
6. 1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Diabetes Care 22:795-800, 1999
7. Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Bartocci L, Brunetti P, Bolli GB: Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 22:568-477, 1999
8. Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler SD, Stephens JW, Home PD: Improved glycaemic control with insulin glargine plus insulin lispro. Diabet Med 23:285-292, 2006
9. Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB: Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with type 1 diabetes mellitus given meal-time lispro insulin. Diabet Med 21:1213-1220, 2004
10. Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB: Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime. Diabetes Care 26:1490-1496, 2003
11. Home PD, Lindholm A, Riis A: Insulin aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial. Diabet Med 17:762-770, 2000
12. DeVries JH, Lindholm A, Jacobsen JL, Heine RJ, Home PD: A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with type 1. Diabet Med 20:312-318, 2003
13. Bott U, Ebrahim S, Hirschberger S, Skovlund SE: Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabet Med 20:626-634, 2003
14. Howorka K, Pumprla J, Schlusche C, Wagner-Nosiska D, Schabmann A, Bradley C: Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue. Qual Life Res 9:915-930, 2000
15. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ 325:746, 2002
16. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R: The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 8:79-91, 1999
17. Bradley C, Speight J: Patient perceptions of diabetes and diabetes therapy. Diabetes Metab Res Rev 18 (Suppl. 3):S64-S69, 2002
18. Bradley C, Lewis K: Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med 7:445-451, 1990
19. Bradley C: The Diabetes Treatment Satisfaction Questionnaire. In Handbook of Psychology and Diabetes:AGuide to Psychological Measurement in Diabetes Research and Practice. Bradley C, Ed. Chur, Switzerland, Harwood Academic Publishers, 1994, p. 111-132
20. Bradley C: Diabetes treatment satisfaction questionnaire: change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care 22:530-532, 1999
21. Bradley C, Witthaus E, Stewart J: Treatment satisfaction and psychological well- being in patients with type 1 diabetes treated with a new long-acting insulin glargine. Diabetes 48:A353, 1998
22. Tamas G, Marre M, Astorga R, Dedov I, Jacobsen J, Lindholm A: Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin. Diabetes Res Clin Pract 54:105-114, 2001
23. Bradley C: Psychological issues in clinical trial design. Ir J Psychol 18:67-87, 1997